The domain III fragment of Japanese encephalitis virus envelope protein: Mouse immunogenicity and liposome adjuvanticity

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2516-2522

  Wu, Suh Chin ^a   Yu, Ching Hung ^a   Lin, Cheng Wen ^a   Chu, I Min ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Domain III; Japanese encephalitis virus; Liposome; Vaccine

Indexed keywords

ADJUVANT; CATION; FREUND ADJUVANT; HYBRID PROTEIN; LIPOSOME; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; THIOREDOXIN; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONING; CONTROLLED STUDY; DRUG SAFETY; ELECTRICITY; EMULSION; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS STRAIN;

EID: 0038064460     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00042-2     Document Type: Article

References (20)

1. Burke DS, Leake CJ. Japanese encephalitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Boca Raton (FL): CRC Press; 1988. p. 69-92.
2. Chia S.-C., Leung P.S.C., Liao C.-P., Huang J.-H., Lee S.T. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Microb. Pathog. 31:2001;9-19.
3. Cox J.C., Coulter A.R. Adjuvants - a classification and review of their modes of action. Vaccine. 15:1997;248-256.
4. Guy B., Pascal N., Francon A., Bonnin A., Gimenez S., Lafay-Vialon E.et al. Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. Vaccine. 19:2001;1794-1805.
5. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E.et al. Structure of dengue virus. Implications for flavivirus organization, maturation, and fusion. Cell. 108:2002;717-725.
6. Lasic D.D. Novel applications of liposomes. Trends Biotechnol. 16:1998;307-321.
7. Mason P.W., Dalrymple J.M., Gentry M.K., McCown J.M., Hoke C.H., Burke D.S.et al. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:1989;2037-2049.
8. McMinn P.C. The molecular basis of virulence of the encephalitogenic flaviviruses. J. Gen. Virol. 78:1997;2711-2722.
9. Monath TP, Heinz FX. Flaviviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. New York: Raven; 1996. p. 961-1034.
10. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S.et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 240:1997;793-797.
11. Nowak T., Wengler G. Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virology. 156:1987;127-137.
12. Rey F.A., Heinz F.X., Mandl C.W., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
13. Rice CM. Flaviviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. New York: Raven; 1996. p. 931-59.
14. Simmons M., Nelson W.M., Wu S.J., Hayes C.G. Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice. Am. J. Trop. Med. Hyg. 58:1998;655-662.
15. Simmons M., Murphy G.S., Hayes C.G. Short report: antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine. Am. J. Trop. Med. Hyg. 65:2001;159-161.
16. Simmons M., Murphy G.S., Kochel T., Raviprakash K., Hayes C.G. Characterization of antibody responses to combinantions of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am. J. Trop. Med. Hyg. 65:2001;420-426.
17. Winkler G., Heinz F.X., Kunz C. Characterization of a disulfide bridge-stabilized antigenic domain of tick-borne encephalitis virus structural glycoprotein. J. Gen. Virol. 68:1987;2239-2244.
18. Wu S.-C., Lian W.-C., Hsu L.-C., Liau M.-Y. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res. 51:1997;173-181.
19. Wu S.-C., Lee S.C. Complete nucleotide sequence and cell-line multiplication pattern of the attenuated variant CH2195LA of Japanese encephalitis virus. Virus Res. 73:2001;91-102.
20. Wu S.-C., Lin C.-W. Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Res. 76:2001;59-69.